These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19270818)

  • 1. Regulation of antiarrhythmic drug propafenone effects on the c-type Kv1.4 potassium channel by PHo and K+.
    Wang Z; Wang S; Li J; Jiang X; Wang N
    J Korean Med Sci; 2009 Feb; 24(1):84-91. PubMed ID: 19270818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel.
    Mergenthaler J; Haverkamp W; Hüttenhofer A; Skryabin BV; Musshoff U; Borggrefe M; Speckmann EJ; Breithardt G; Madeja M
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Apr; 363(4):472-80. PubMed ID: 11330342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propafenone on Kv1.4 inactivation.
    Tian L; Jiang X; Rasmusson R; Wang S
    J Physiol Biochem; 2006 Dec; 62(4):263-70. PubMed ID: 17615952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of amiodarone on Kv1.4 channel C-type inactivation: comparison of its effects with those induced by propafenone and verapamil.
    Xu L; Huang C; Chen J; Jiang X; Li X; Bett GC; Rasmusson RL; Wang S
    Pharmazie; 2008 Jun; 63(6):475-9. PubMed ID: 18604993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
    Madeja M; Leicher T; Friederich P; Punke MA; Haverkamp W; Musshoff U; Breithardt G; Speckmann EJ
    Mol Pharmacol; 2003 Mar; 63(3):547-56. PubMed ID: 12606761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diltiazem and propafenone on the inactivation and recovery kinetics of fKv1.4 channel currents expressed in Xenopus oocytes.
    Zhang D; Wang SM; Chen H; Jiang XJ; Chao SP
    Acta Pharmacol Sin; 2011 Apr; 32(4):465-77. PubMed ID: 21468083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ginseng-spikenard heart-nourishing capsule on inactivation of C-type Kv1.4 potassium channel.
    Wang ZQ; Jiang XJ; Zhang GY; Chen M; Tong CF; Zhang D
    Pak J Pharm Sci; 2016 Sep; 29(5):1513-1517. PubMed ID: 27731805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channels.
    Schmidt C; Wiedmann F; Schweizer PA; Becker R; Katus HA; Thomas D
    Eur J Pharmacol; 2013 Dec; 721(1-3):237-48. PubMed ID: 24070813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of antiarrhythmic drugs flecainide and verapamil on fKv1.4ΔN channel currents in Xenopus oocytes.
    Chen H; Zhang D; Chao SP; Ren JH; Xu L; Jiang XJ; Wang SM
    Acta Pharmacol Sin; 2013 Feb; 34(2):221-30. PubMed ID: 23202797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes.
    Rolf S; Haverkamp W; Borggrefe M; Musshoff U; Eckardt L; Mergenthaler J; Snyders DJ; Pongs O; Speckmann EJ; Breithardt G; Madeja M
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jul; 362(1):22-31. PubMed ID: 10935529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis involved in the blocking effect of antidepressant metergoline on C-type inactivation of Kv1.4 channel.
    Bai HW; Eom S; Yeom HD; Nguyen KVA; Lee J; Sohn SO; Lee JH
    Neuropharmacology; 2019 Mar; 146():65-73. PubMed ID: 30465811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Human Kv1.4 Channel Activity by the Antidepressant Metergoline.
    Yeom HD; Lee JH
    Biol Pharm Bull; 2016; 39(6):1069-72. PubMed ID: 27251511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The low-potency, voltage-dependent HERG blocker propafenone--molecular determinants and drug trapping.
    Witchel HJ; Dempsey CE; Sessions RB; Perry M; Milnes JT; Hancox JC; Mitcheson JS
    Mol Pharmacol; 2004 Nov; 66(5):1201-12. PubMed ID: 15308760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of Conorfamide-Sr3 on Human Voltage-Gated Kv1 Potassium Channel Subtypes.
    López-Vera E; Martínez-Hernández L; Aguilar MB; Carrillo E; Gajewiak J
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32823677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propafenone on K currents in human atrial myocytes.
    Seki A; Hagiwara N; Kasanuki H
    Br J Pharmacol; 1999 Mar; 126(5):1153-62. PubMed ID: 10205003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels.
    Arias C; González T; Moreno I; Caballero R; Delpón E; Tamargo J; Valenzuela C
    Cardiovasc Res; 2003 Mar; 57(3):660-9. PubMed ID: 12618228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade action of ketanserin and increasing effect of potassium ion on Kv1.3 channels expressed in Xenopus oocytes.
    Wang X; Liao Y; Zou A; Li L; Tu D
    Pharmacol Res; 2007 Aug; 56(2):148-54. PubMed ID: 17582781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels.
    Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of propafenone and 5-hydroxy-propafenone on hKv1.5 channels.
    Franqueza L; Valenzuela C; Delpón E; Longobardo M; Caballero R; Tamargo J
    Br J Pharmacol; 1998 Nov; 125(5):969-78. PubMed ID: 9846634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlapping binding sites of structurally different antiarrhythmics flecainide and propafenone in the subunit interface of potassium channel Kv2.1.
    Madeja M; Steffen W; Mesic I; Garic B; Zhorov BS
    J Biol Chem; 2010 Oct; 285(44):33898-905. PubMed ID: 20709754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.